Need a specific person's email?
Browse Myris Therapeutics's employee directory (about 24 employees) and reveal verified emails free.
Myris Therapeutics's most common email format is First.Last@biohybridsolutions.com (ex. John.Doe@biohybridsolutions.com), used for 73% of biohybridsolutions.com addresses. Myris Therapeutics uses 5 email patterns across 2 domains: biohybridsolutions.com and myristx.com. Percentages are the share of addresses within each domain.
| Format | Example | Share of biohybridsolutions.com |
|---|---|---|
| First.Last@biohybridsolutions.comMost common | John.Doe@biohybridsolutions.com | |
| First@biohybridsolutions.com | John@biohybridsolutions.com | |
| Last@biohybridsolutions.com | Doe@biohybridsolutions.com | |
| LastF@biohybridsolutions.com | DoeJ@biohybridsolutions.com |
| Format | Example | Share of myristx.com |
|---|---|---|
| FLast@myristx.comMost common | JDoe@myristx.com |
Browse Myris Therapeutics's employee directory (about 24 employees) and reveal verified emails free.
Biotechnology ResearchPennsylvania, United States11-50 Employees
Myris Therapeutics, based in Pittsburgh, Pennsylvania, operates in the biotechnology research sector. It develops antibody-drug conjugates with very high drug-to-antibody ratios by combining traditional ADC design with next-generation polymer chemistry. The company maintains a compact, specialized team to advance this platform. Positioned in the ADC development space, its work targets the biotechnology and pharmaceutical research community seeking advanced conjugate technologies. In August 2022, the company announced the appointment of Mark Murcko, Ph.D., to its board.
Most common format
First.Last@biohybridsolutions.com
Example: John.Doe@biohybridsolutions.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.